Literature DB >> 12620647

Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE.

Annemarie Ledeboer1, Anne Wierinckx, John G J M Bol, Sarah Floris, Chantal Renardel de Lavalette, Helga E De Vries, Timo K van den Berg, Christine D Dijkstra, Fred J H Tilders, Anne-Marie van dam.   

Abstract

Adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) mediate leukocyte infiltration into the CNS, in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Because exogenous interleukin-10 (IL-10) inhibits ICAM-1 and VCAM-1 expression and clinical EAE, we hypothesize that endogenous IL-10 signaling may suppress expression of adhesion molecules. In a rat model of chronic relapsing EAE, expression levels of IL-10 and its receptor (IL-10R1), ICAM-1 and VCAM-1 mRNA in the spinal cord are markedly increased, whereas levels of IL-10 mRNA remain relatively low. The temporal pattern of mRNA and protein expression showed marked differences between spinal cord levels. During relapse, IL-10, IL-10R1, ICAM-1, VCAM-1 mRNA levels and neurological scores show positive correlations. We conclude that endogenous IL-10 is not a crucial factor inhibiting adhesion molecule expression in this model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620647     DOI: 10.1016/s0165-5728(03)00031-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

Review 1.  Long-term control of neuropathic pain in a non-viral gene therapy paradigm.

Authors:  E M Sloane; R G Soderquist; S F Maier; M J Mahoney; L R Watkins; E D Milligan
Journal:  Gene Ther       Date:  2009-03-05       Impact factor: 5.250

2.  Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.

Authors:  Lisa C Loram; Keith A Strand; Frederick R Taylor; Evan Sloane; Anne-Marie Van Dam; Jayson Rieger; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2015-01-31       Impact factor: 7.217

3.  IL-10 and IL-1β mediate neuropathic-pain like behavior in the ventrolateral orbital cortex.

Authors:  Qingdong Shao; Yufei Li; Qiang Wang; Jianning Zhao
Journal:  Neurochem Res       Date:  2015-01-24       Impact factor: 3.996

4.  PEGylation of interleukin-10 for the mitigation of enhanced pain states.

Authors:  Ryan G Soderquist; Erin D Milligan; Jacqueline A Harrison; Raymond A Chavez; Kirk W Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

5.  Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Authors:  Peter M Grace; Lisa C Loram; John P Christianson; Keith A Strand; Johanna G Flyer-Adams; Kathryn R Penzkover; John R Forsayeth; Anne-Marie van Dam; Melissa J Mahoney; Steven F Maier; Raymond A Chavez; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2016-05-14       Impact factor: 7.217

6.  Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.

Authors:  Lisa C Loram; Jacqueline A Harrison; Evan M Sloane; Mark R Hutchinson; Paige Sholar; Frederick R Taylor; Debra Berkelhammer; Benjamen D Coats; Stephen Poole; Erin D Milligan; Steven F Maier; Jayson Rieger; Linda R Watkins
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

7.  Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.

Authors:  Evan Sloane; A Ledeboer; W Seibert; B Coats; M van Strien; S F Maier; K W Johnson; R Chavez; L R Watkins; L Leinwand; E D Milligan; A M Van Dam
Journal:  Brain Behav Immun       Date:  2008-09-20       Impact factor: 7.217

8.  Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury.

Authors:  Zhi-Hong Wang; Xiao-Yan Zeng; Shui-Ping Han; Gui-Xiang Fan; Jun-Yang Wang
Journal:  Neurochem Res       Date:  2012-05-15       Impact factor: 3.996

Review 9.  Spinal interleukin-10 therapy to treat peripheral neuropathic pain.

Authors:  Erin D Milligan; Kathryn R Penzkover; Ryan G Soderquist; Melissa J Mahoney
Journal:  Neuromodulation       Date:  2012-06-01

10.  Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.

Authors:  Andrew J Kwilasz; Laurel S Todd; Julissa C Duran-Malle; Anouk E W Schrama; Eric H Mitten; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Xiaohui Wang; Anne-Marie Van Dam; Steven F Maier; Kenner C Rice; Linda R Watkins; Ruth M Barrientos
Journal:  Behav Brain Res       Date:  2020-09-06       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.